Salbutamol inhaler
Beta-2 adrenergic agonist (bronchodilator)
What it is used for
Reversible bronchospasm associated with acute or chronic asthma, bronchitis or other obstructive pulmonary disease. Clinical selection for Salbutamol inhaler should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Beta-2 adrenergic agonist (bronchodilator). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Paradoxical bronchospasm. Hypokalaemia with high dose/nebs especially with steroids/diuretics/xanthines. CV disease: tachycardia/arrhythmia risk. Thyrotoxicosis caution.
Possible side effects
Muscle cramps, tachycardia, palpitation, fine muscle tremor, headache, peripheral vasodilation, restlessness, allergic reactions, fear, fatigue, insomnia, dizziness.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.